Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Pancreas Cancer

    Despite its infrequency, pancreatic cancer is the fourth leading cause of cancer death in USA with an estimated 42,140 new cases and 36,800 deaths projected in the USA for 2010 [1]. Although mortality rates ha...

    Robert C. Miller, Vincenzo Valentini, Adyr Moss in Intraoperative Irradiation (2011)

  2. No Access

    Chapter

    Primary Colorectal Cancer

    Carcinoma of the rectum is a heterogeneous disease. At one end of the clinical spectrum, a small number of patients present with superficially invasive cancers who are well served by limited ­procedures, such ...

    Nils D. Arvold, Theodore S. Hong, Christopher G. Willett in Intraoperative Irradiation (2011)

  3. No Access

    Chapter

    Modern Radiation Therapy Approaches: Targeted and Ablative Strategies

    New technological advances in radiation oncology have allowed safe, high dose delivery of radiation therapy with ablative intent. In this chapter, new technologies such as intensity-modulated radiation therapy...

    Theodore S. Hong in Interventional Oncology (2012)

  4. Article

    Open Access

    ACR Appropriateness Criteria®  Resectable Rectal Cancer

    The management of resectable rectal cancer continues to be guided by clinical trials and advances in technique. Although surgical advances including total mesorectal excision continue to decrease rates of loca...

    William E Jones III, Charles R Thomas Jr, Joseph M Herman in Radiation Oncology (2012)

  5. Article

    Dosimetric predictors of nausea and vomiting: an exploratory analysis of a prospective phase I/II trial with neoadjuvant accelerated short-course radiotherapy and capecitabine for resectable pancreatic cancer

    We performed an exploratory analysis to identify dose-volume parameters that may predict treatment-induced nausea and vomiting among patients receiving hypofractionated radiotherapy to the pancreas.

    Yolanda D. Tseng, Jennifer Y. Wo, Marek Ancukiewicz in Journal of Radiation Oncology (2013)

  6. Article

    Stereotactic body radiation therapy (SBRT) for pancreatic and non-hepatobiliary gastrointestinal (GI) malignancies

    In this review article, we review the current literature addressing the use of stereotactic body radiation therapy (SBRT) in non-hepatobiliary gastrointestinal malignancies. For many gastrointestinal malignanc...

    John G. Phillips, Jennifer Y. Wo, Theodore S. Hong in Journal of Radiation Oncology (2013)

  7. No Access

    Article

    Treatment of Stage II–III Rectal Cancer Patients

    The role and sequencing of radiotherapy in the management of T3–4 or node-positive rectal cancer has evolved over the last few decades. Given the significant local failure rate following surgery alone, both pr...

    Miranda B. Kim, Theodore S. Hong, Jennifer Y. Wo in Current Oncology Reports (2013)

  8. No Access

    Chapter

    Emerging Techniques in Image-Guided Radiation Therapy and Stereotactic Body Radiation Therapy

    Locoregional recurrence is the primary failure pattern for biliary tract and gallbladder cancers. However, the use of external beam radiation therapy in the treatment for these cancers, particularly cholangioc...

    John G. Phillips, John A. Wolfgang in Biliary Tract and Gallbladder Cancer (2014)

  9. No Access

    Article

    Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

    Preoperative chemoradiation (CRT) for locally advanced rectal adenocarcinoma achieves pathologic complete response (pCR) in 8–20 % of patients. Mutations in critical cancer genes may contribute to lack of pCR....

    Andrea L. Russo, David P. Ryan, Darrell R. Borger in Journal of Gastrointestinal Cancer (2014)

  10. No Access

    Article

    Genetic Mechanisms in Interval Colon Cancers

    The factors underlying the development of interval colon cancers are not well defined and are likely heterogeneous. We sought to determine whether there are distinct molecular properties associated with interv...

    James M. Richter, Maria Simona Pino, Thomas R. Austin in Digestive Diseases and Sciences (2014)

  11. No Access

    Article

    Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach

    Delayed recovery after gastrectomy may preclude the administration of adjuvant therapy in a significant percentage of patients who undergo elective gastrectomy as the initial therapy for gastric cancer. Clinic...

    Eva Fuentes, Rima Ahmad, Theodore S. Hong in Journal of Gastrointestinal Surgery (2016)

  12. No Access

    Article

    Advances in the Management of Gastric and Gastroesophageal Cancers

    Management of gastric and gastroesophageal cancers is a complex, evolving paradigm. Involvement of multimodality specialties is the key. In gastric cancer, data are conflicting with regard to the specific role...

    Sophia C. Kamran, Theodore S. Hong, Jennifer Y. Wo in Current Oncology Reports (2016)

  13. No Access

    Article

    Predictors of Lymph Node Metastasis in Western Early Gastric Cancer

    The application of endoscopic and local resection for early gastric cancer (EGC) is limited by the risk of regional lymph node (LN) metastasis. We sought to determine the incidence and predictors of LN metasta...

    Rima Ahmad, Namrata Setia, Benjamin H. Schmidt in Journal of Gastrointestinal Surgery (2016)

  14. No Access

    Chapter

    Role of Radiation Therapy for Intrahepatic Cholangiocarcinoma

    Intrahepatic cholangiocarcinoma is a rare diagnosis, yet the incidence continues to rise worldwide. As these tumors often clinically present at an advanced stage, the majority of patients have unresectable dis...

    Sagar A. Patel, Florence K. Keane, Theodore S. Hong in Primary and Metastatic Liver Tumors (2018)

  15. Article

    Open Access

    Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy

    Radiotherapy shows excellent local control in liver cancers but carries the risk of radiation-induced liver dysfunction and liver failure. We conducted a study of plasma hepatocyte growth factor (HGF) in a cli...

    Theodore S. Hong, Clemens Grassberger, Beow Y. Yeap in npj Precision Oncology (2018)

  16. No Access

    Chapter

    Radiotherapy

    Intrahepatic cholangiocarcinoma (ICC) is a rare biliary malignancy, with a significant risk of both extensive local progression and distant metastasis. While resection has long stood as the mainstay of curativ...

    Florence K. Keane, Theodore S. Hong in Intrahepatic Cholangiocarcinoma (2019)

  17. No Access

    Article

    A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types

    Triple-negative breast cancers (TNBC) are often resistant to treatment with ionizing radiation (IR). We sought to investigate whether pharmacologic inhibition of Chk1 kinase, which is commonly overexpressed in...

    Patrick H. Dinkelborg, Meng Wang, Liliana Gheorghiu in Breast Cancer Research and Treatment (2019)

  18. Article

    Open Access

    Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events

    Immune checkpoint inhibitors (ICI) have demonstrated remarkable efficacy as cancer therapeutics, however, their use remains limited due to the development of immune related adverse events (irAEs). Immune relat...

    Yousef R. Badran, Justine V. Cohen in Journal for ImmunoTherapy of Cancer (2019)

  19. No Access

    Article

    Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

    During cancer therapy, tumor heterogeneity can drive the evolution of multiple tumor subclones harboring unique resistance mechanisms in an individual patient13. Previous case reports and small case series have ...

    Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal in Nature Medicine (2019)

  20. No Access

    Article

    Clinical impact of PET/MR in treated colorectal cancer patients

    The primary aim of the present study was to evaluate if PET/MR induced management changes versus standard of care imaging (SCI) in treated colorectal cancer patients. The secondary aim was to assess the stagin...

    Barbara J. Amorim, Theodore S. Hong in European Journal of Nuclear Medicine and M… (2019)

previous disabled Page of 2